UBS AM’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $79.4M | Sell |
|
|||||
|
2025
Q2 | $87.6M | Sell |
|
|||||
|
2025
Q1 | $92M | Buy |
|
|||||
|
2024
Q4 | $73M | Sell |
|
|||||
|
2024
Q3 | $109M | Buy |
|
|||||
|
2024
Q2 | $53.4M | Buy |
|
|||||
|
2024
Q1 | $14.1M | Sell |
|
|||||
|
2023
Q4 | $15.2M | Buy |
|
|||||
|
2023
Q3 | $13.3M | Buy |
|
|||||
|
2023
Q2 | $13.1M | Hold |
|
|||||
|
2023
Q1 | $13.1M | Buy |
|
|||||
|
2022
Q4 | $15.1M | Buy |
|
|||||
|
2022
Q3 | $16.3M | Buy |
|
|||||
|
2022
Q2 | $14.3M | Buy |
|
|||||
|
2022
Q1 | $14M | Sell |
|
|||||
|
2021
Q4 | $19.6M | Buy |
|
|||||
|
2021
Q3 | $21.9M | Buy |
|
|||||
|
2021
Q2 | $33.7M | Buy |
|
|||||
|
2021
Q1 | $17M | Sell |
|
|||||
|
2020
Q4 | $34.3M | Sell |
|
|||||
|
2020
Q3 | $17.7M | Buy |
|
|||||
|
2020
Q2 | $11.9M | Buy |
|
|||||
|
2020
Q1 | $1.16M | Buy |
|
|||||
|
2019
Q4 | $1.01M | Sell |
|
|||||
|
2019
Q3 | $917K | Buy |
|
|||||
|
2019
Q2 | $1.03M | Buy |
|
|||||
|
2019
Q1 | $691K | Buy |
|
|||||
|
2018
Q4 | $409K | Buy |
|
|||||
|
2018
Q3 | $320K | Buy |
|